Aravind Asokan, PhD, will lead a new strategic partnership with Danaher Corporation to form the first Danaher Beacon for Gene Therapy Innovation, a new initiative designed to access breakthrough science to create technologies and applications that will improve human health. 

A family history of cancer and genetic variants that might be inherited appear to be important risk factors for Black men diagnosed with early-onset prostate cancer, a study involving Duke Health researchers has found.

Since the early 1980s, Duke staff and faculty showed courage, compassion in the face of the HIV epidemic

Rana Gupta, PhD, a professor of medicine and Duke Science and Technology Scholar, says fat is more than an energy bank: it’s “a very talkative, chatty tissue,” and what it says can tell us a lot about how fat affects heart disease, diabetes and overall health.

Randomized study led by Columbia University and Duke's Murali Doraiswamy determined that crossword puzzles have an advantage over cognitive computer games for memory functioning in older adults with mild cognitive impairment.

We are hard-wired to love sweets, but, as is so often the case, too much of a good thing can be a bad thing: overconsumption of sugar raises the risk of obesity, heart disease, type 2 diabetes, and other health conditions.

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

Brain, gut and immune system were fine-tuned after split from common ancestor of chimpanzees

To bridge the communication and coordination gap and break down the care siloes, Duke population health scholars Leah Zullig and Kevin Oeffinger from the Duke University School of Medicine developed ONE TEAM.

Svati Shah, MD, associate dean for genomics and professor of medicine, received the Genomic and Precision Medicine Mentoring Award from the American Heart Association.